Bacterial secondary metabolites have been studied for decades for their usefulness as drugs, such as antibiotics. However, the identification of new structures has been decelerating, in part due to rediscovery of known compounds. Meanwhile, multi-resistant pathogens continue to emerge, urging […]
Discovery of novel antibiotics is crucial for combating rapidly spreading antimicrobial resistance and new infectious diseases. Most of the clinically used antibiotics are natural products—secondary metabolites produced by soil microbes that can be cultured in the lab. Rediscovery of these […]
As a result of the continuous evolution of drug resistant bacteria, new antibiotics are urgently needed. Encoded by biosynthetic gene clusters (BGCs), antibiotic compounds are mostly produced by bacteria. With the exponential increase in the number of publicly available, sequenced […]
IDENER RESEARCH & DEVELOPMENT AGRUPACION DE INTERES ECONOMICO
Calle Earle Ovington 24-8, La Rinconada Sevilla, 41300, ES
Sustainable Exploitation of bio-based Compounds Revealed and Engineered from naTural sources Topic: FNR-11-2020 Prospecting aquatic and terrestrial natural biological resources for biologically active compounds
This Project has received funding from the European Community’s H2020 Programme under the grant agreement Nr. 101000794. Funding Scheme: H2020-FNR-2020-2.
© Copyright 2023 by EXELISIS
